Directors’ Dealings | 25 May 2012 20:16

DGAP-DD: STRATEC Biomedical AG english

Notification concerning transactions by persons performing managerial responsibilities pursuant to section 15a of the WpHG Directors’ Dealings notification transmitted by DGAP – a company of EquityStory AG. The person with duty of notification is solely responsible for the content of this announcement. ————————————————————————— Details of the person subject to the disclosure requirement Last name: Wolfinger First name: Marcus Position: Member of a managing body Information about the transaction with duty of notification Description of the financial instrument: STRATEC Biomedical AG / Ordinary Share ISIN/WKN of the financial instrument: DE0007289001 Type of transaction: Sale Date: 24.05.2012 Price: 29.9878 Currency: EUR No. of items: 4500 Total amount traded: 134945.10 Place: außerbörslich / OTC Explanation for publication: Cashless exercise (exercising of stock options incl. block sale of stocks to investor via bank; strike price for underlying stock options: Euro 9.23 per stock option). The shares thereby sold result from stock options granted as a component of compensation. Information about the company with duty of publication Issuer: STRATEC Biomedical AG Gewerbestr. 37 75217 Birkenfeld Deutschland ISIN: DE0007289001 WKN: 728900 End of Directors’ Dealings Notification (c) DGAP 25.05.2012 DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de ID 15303